Skip to content

Determination of the Glycemic Index of Breads made from a Novel Wheat

A randomised study determining the glycemic index of breads made from novel wheat in healthy volunteers with a normal fasting glucose (3.5-5.5 mmol/L)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12606000366550
Acronym
Novel wheat
Enrollment
14
Registered
2006-08-22
Start date
2006-08-10
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To compare changes in blood sugar levels (glycemic index) after consumption of bread made with the new wheat flour with the response obtained following consumption of bread manufactured from conventional wheat flour.

Interventions

All participants will be randomised to eat one meal of 100gm of bread from the new wheat flour (Yammamori) . There are 3 breads, 25%, 50% and 100% Yammamori wheat. The response to a reference carbohydrate (sugar drink) is used as a standard for comparison in these tests on 3 occasions due to the variability of the glucose response.

Sponsors

Commonwealth Scientific Industrial Research Organisation, Human Nutrition
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Normal fasting blood glucose concentration (3.5-5.5 mmol/L).

Exclusion criteria

Presence of diabetes (self-reported)Sufferers of bleeding disordersKnown food allergy, hypersensitivity or intolerance to cereal foods (eg celiac sprue) Taking medications known to influence glucose tolerance (oral contraceptives are excepted) such as sulphonylureas, metformin and thiazolidinediones.Persons considered by the investigator to be unwilling, unlikely or unable to comprehend or comply with the study protocol Participation in another research study within 30 days preceding the start of this studyHistory or presence of GI, renal or hepatic disease of any cause.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026